<SEC-DOCUMENT>0001193125-25-245098-index.html : 20251021
<SEC-HEADER>0001193125-25-245098.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021160703
ACCESSION NUMBER:		0001193125-25-245098
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20251020
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adawi Kamal
		CENTRAL INDEX KEY:			0001788393
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36076
		FILM NUMBER:		251407114

	MAIL ADDRESS:	
		STREET 1:		C/O EXAGEN INC.
		STREET 2:		1261 LIBERTY WAY, SUITE C
		CITY:			VISTA
		STATE:			CA
		ZIP:			92131

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FATE THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001434316
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				651311552
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		12278 SCRIPPS SUMMIT DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92131
		BUSINESS PHONE:		858.875.1803

	MAIL ADDRESS:	
		STREET 1:		12278 SCRIPPS SUMMIT DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92131
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>fate-ex24.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: fate-ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>